Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines
2017 ◽
Vol 32
(7)
◽
pp. 229-238
◽
2011 ◽
Vol 138
(3)
◽
pp. 491-499
◽
2004 ◽
Vol 10
(22)
◽
pp. 7764-7774
◽
2010 ◽
Vol 397
(2)
◽
pp. 296-300
◽
2009 ◽
Vol 117
(6)
◽
pp. 663-668
◽
1998 ◽
Vol 118
(3)
◽
pp. 428-431
◽